PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 26-50 of 369

  • Gedatolisib
    Cat. No.
    A11079

    Gedatolisib (PKI-587)

    Synonyms: PKI587

    Gedatolisib (PKI-587) is a highly potent PI3K/mTOR kinase inhibitor that inhibits PI3K-α,β,γ, δ isoforms and mTOR with IC50 of 0.4, 6.0, 5.4, 6.0 and 1.6 nM respectively.  

    1 mg
    $35.00
    2 mg
    $40.00
    All 8 sizes
  • ETP-46464
    Cat. No.
    A13328

    ETP-46464

    ETP-46464 is a potent and selective inhibitor of ATR with IC50 of 25 nM.

    2 mg
    $25.00
    5 mg
    $50.00
    All 7 sizes
  • PI-3065
    Cat. No.
    A14338

    PI-3065

    PI-3065 is a small molecule and selective inhibitor of p110δ kinase with an Ki value of 1.5nM and IC50 value of 5nM

    5 mg
    $35.00
    10 mg
    $65.00
    All 6 sizes
  • Samotolisib
    Cat. No.
    A16126

    Samotolisib (LY3023414)

    Synonyms: LY-3023414

    Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, mTOR and DNA-PK, extracted from patent WO/2012097039A1, compound example 1, has an IC50 of 64.9 nM, 42.1 nM, 10.6 nM, 19.1 nM for Akt1(pT308), Akt1 (pS473), P70S6(pT389), S6RP(pS240/242).

    5 mg
    $35.00
    10 mg
    $65.00
    All 7 sizes
  • AZD8835
    Cat. No.
    A16352

    AZD8835

    AZD8835 is a potent and selective inhibitor of PI3Kα and PI3Kδ with IC50 of 5.7 nM and 6.2 nM, with selectivity against PI3Kβ (IC50 431 nM) and PI3Kγ (IC50 90 nM).

    5 mg
    $35.00
    10 mg
    $55.00
    All 6 sizes
  • SF2523
    Cat. No.
    A20557

    SF2523

    SF2523 is a highly selective and potent inhibitor of PI3K with IC50s of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM for PI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively.

    1 mg
    $25.00
    5 mg
    $65.00
    All 8 sizes
  • AS-605240
    Cat. No.
    A10088

    AS-605240

    AS-605240 is an orally active inhibitor of PI3-kinase γ that inhibits human recombinant PI3Kγ, α, β, and δ in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.

    5 mg
    $25.00
    10 mg
    $35.00
    All 7 sizes
  • IC-87114
    Cat. No.
    A10463

    IC-87114

    IC-87114 was the first isoform-selective PI3K inhibitor :p110M-NM-4(IC50 = 0.13 M-BM-5M) vs. p110M-NM-1(IC50 = 200 M-BM-5M), p110M-NM-2(IC50 = 16 M-BM-5M) and p110M-NM-3(IC50 = 61 M-BM-5M).

    2 mg
    $25.00
    5 mg
    $45.00
    All 8 sizes
  • PIK-293
    Cat. No.
    A10727

    PIK-293

    PIK-293 is a PI3-K inhibitor. PIK-293 inhibits the p110α, p110β, p110δ. PIK-293 is the parent compound of PIK-294.

    1 mg
    $35.00
    2 mg
    $50.00
    All 8 sizes
  • PIK-294
    Cat. No.
    A10728

    PIK-294

    PIK-294 is a PI3 Kinase inhibitor that is 20- to 60-fold more potent than the parent compound, PIK-293. It is one of the most potent p110δ-selective inhibitors that has been reported.

    1 mg
    $25.00
    5 mg
    $35.00
    All 7 sizes
  • PIK-90
    Cat. No.
    A10730

    PIK-90

    PIK-90 is a synthetic phosphoinositide 3-kinase (PI3K) inhibitor with IC50 values (nM) of 11, 350, 18, and 58 for p110 α, β, γ and δ isoforms, low mTOR activity.

    5 mg
    $30.00
    10 mg
    $40.00
    All 5 sizes
  • Quercetin dihydrate
    Cat. No.
    A10765

    Quercetin dihydrate (Sophoretin)

    Synonyms: Sophoretin; Meletin; Quercetine; Xanthaurine; Quercetol; Quercitin

    Quercetin inhibits many enzyme systems including tyrosine protein kinase, phospholipase A2, phosphodiesterases, mitochondrial ATPase, PI 3-kinase and protein kinase C.

    100 mg
    $20.00
    200 mg
    $30.00
    All 4 sizes
  • Desmethyl-VS-5584
    Cat. No.
    A10900

    Desmethyl-VS-5584

    Desmethyl-VS-5584 is a demethyl analogue of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.

    1 mg
    $40.00
    2 mg
    $60.00
    All 7 sizes
  • TG100-115
    Cat. No.
    A10922

    TG100-115

    TG100-115 inhibits PI3K γ and -δ(IC50 values of 83 and 235 nM, respectively).

    1 mg
    $30.00
    5 mg
    $55.00
    All 8 sizes
  • XL765
    Cat. No.
    A10997

    XL765

    XL765 is a PI3K/mTOR dual kinase inhibitor and it is more potent compared to an agent that inhibits either PI3K kinase or mTOR kinase alone.

    1 mg
    $25.00
    2 mg
    $35.00
    All 9 sizes
  • Omipalisib
    Cat. No.
    A11035

    Omipalisib (GSK2126458)

    Synonyms: GSK-2126458

    GSK2126458 is a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.

    2 mg
    $35.00
    5 mg
    $55.00
    All 7 sizes
  • PKI-402
    Cat. No.
    A11089

    PKI-402

    PKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.

    5 mg
    $35.00
    10 mg
    $60.00
    All 5 sizes
  • AS-252424
    Cat. No.
    A11099

    AS-252424

    AS-252424 is a potent inhibitor of PI3K with selectivity for the γ isoform. It inhibits human recombinant PI3Kγ, α, β, and δ with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.

    1 mg
    $25.00
    2 mg
    $40.00
    All 9 sizes
  • NVP-BGT226
    Cat. No.
    A11162

    NVP-BGT226

    Synonyms: BGT226

    NVP-BGT226, novel phosphoinositide 3-kinase/mTOR dual inhibitor, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.

    1 mg
    $25.00
    5 mg
    $65.00
    All 8 sizes
  • CH5132799
    Cat. No.
    A11169

    CH5132799

    CH5132799 is a novel class I PI3K inhibitor, which exhibited a strong inhibitory activity especially against PI3Kα (IC(50)=0.014 μM).

    1 mg
    $50.00
    2 mg
    $80.00
    All 9 sizes
  • CAY10505
    Cat. No.
    A11196

    CAY10505

    CAY10505 is a potent inhibitor of PI3K, selectively inhibiting the γ isoform (IC50 = 30 nM) better than the α, β, and δ isoforms (IC50 = 0.94, 20, and 20 μM, respectively).

    10 mg
    $25.00
    25 mg
    $45.00
    All 7 sizes
  • AS-604850
    Cat. No.
    A11197

    AS-604850

    AS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.

    1 mg
    $20.00
    5 mg
    $25.00
    All 8 sizes
  • D-106669
    Cat. No.
    A11198

    D-106669

    D-106669 is a highly potent and selective PI3K inhibitor, (PI3Kα IC50 <10 nM, >3 log selectivity against tyrosine or serine/threonine kinases, except ERK1 and 2).

    5 mg
    $230.00
    10 mg
    $320.00
    All 4 sizes
  • A66
    Cat. No.
    A11202

    A66

    The S-enantiomer of A66 is a potent inhibitor of the p110alpha isoform of PI 3-kinase (PIK3CA).

    2 mg
    $25.00
    5 mg
    $40.00
    All 8 sizes
  • PP121
    Cat. No.
    A11207

    PP121

    PP121 is a dual inhibitor of receptor tyrosine kinases (RTKs) (IC50 < 0.02 μM for Abl, Src, VEGFR-2 and PDGFR) and PI 3-K family kinases (IC50 < 0.06 μM for p110α, DNA-PK and mTOR).

    5 mg
    $45.00
    10 mg
    $70.00
    All 6 sizes

Items 26-50 of 369

Added to your cart

View Cart Checkout

    Loading...